Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
COSCIENS Biopharma ( (TSE:CSCI) ) has issued an announcement.
On May 26, 2025, COSCIENS Biopharma Inc. acknowledged receiving director nominations from Goodwood Fund and Puccetti Funds Management Inc. for its upcoming Annual and Special Meeting of Shareholders. The company’s Board of Directors is reviewing the nominations and remains committed to acting in the best interests of COSCIENS and its shareholders. This development could influence the company’s governance and strategic direction, impacting its market positioning and stakeholder relations.
More about COSCIENS Biopharma
COSCIENS Biopharma Inc. is a life sciences company that develops and commercializes a diversified portfolio of cosmeceutical, nutraceutical, and pharmaceutical products. The company utilizes proprietary extraction technology to produce active ingredients from renewable plant resources, which are used in cosmeceutical products and are being developed for potential nutraceutical and pharmaceutical applications. COSCIENS is listed on the NASDAQ Capital Market and the Toronto Stock Exchange under the ticker symbol ‘CSCI’.
Average Trading Volume: 2,289
Technical Sentiment Signal: Sell
Current Market Cap: C$15.35M
For a thorough assessment of CSCI stock, go to TipRanks’ Stock Analysis page.